Key Quantitative Figures
The addendum discloses an indicative capital allocation deployment schedule:
- FY 2027: ~₹1,900 crores
- FY 2028: ~₹3,000 crores
- FY 2029: ~₹2,000 crores
Total indicative deployment: ~₹6,900 crores over three fiscal years
Purpose and Rationale
The capital allocation is intended to support investments in operating subsidiaries, joint ventures, and other strategic business initiatives. The addendum was issued in response to investor and stakeholder queries received in relation to the proposed capital allocation framework.
Important Qualifications
The deployment schedule is indicative in nature and actual deployment may vary depending on:
- Business requirements
- Acquisition opportunities
- Market conditions
- Regulatory approvals
- Funding requirements
- Strategic priorities
- Other commercial considerations prevailing from time to time
Parties Involved
- Hemish Purushottam, Company Secretary and Compliance Officer (signed the submission)
- Dr. Azad Moopen, Executive Chairman (signed the addendum)
- BSE Limited and National Stock Exchange of India Limited (recipients)
Additional Information
The addendum forms an integral part of the AGM Notice dated 5 August 2026. All other terms, information and disclosures contained in the original AGM Notice remain unchanged except for the additional information provided in this addendum.